Bronchial Epithelial Cultures and Kawasaki Disease
支气管上皮培养与川崎病
基本信息
- 批准号:7599596
- 负责人:
- 金额:$ 19.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-03 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAneurysmAntibodiesAntigensArteriesBase SequenceBlast CellCD8-Positive T-LymphocytesCell Culture SystemCell Culture TechniquesCellsChildChildhoodCiliaCiliated Bronchial Epithelial CellClinicalCollecting CellCoronary AneurysmCoronary arteryCultured CellsCytoplasmic InclusionDeveloped CountriesDeveloping CountriesDevelopmentDiagnosisDiagnostic testsDiseaseElectron MicroscopyEpidemiologic StudiesEpithelialEpithelial CellsEtiologyGenesGeneticGenomeGoalsHeart DiseasesHumanImmune responseImmunoglobulin AImmunoglobulin Variable RegionImmunohistochemistryImmunologicsIn VitroInclusion BodiesIncubatedInfectious AgentInfiltrationLaboratoriesLungMethodsMucocutaneous Lymph Node SyndromeMyocardial InfarctionNucleic AcidsNucleic acid sequencingPathogenesisPatientsPatternPlasma CellsPopulationPrevention therapyReportingResearch ProposalsRespiratory SystemRespiratory tract structureSamplingSequence AnalysisSiteStaining methodStainsSudden DeathSupporting CellSystemTechniquesTestingTimeTissuesTransmission Electron MicroscopyVirus Diseasesbronchial epitheliumdisorder controllight transmissionmacrophagenovelpathogenpreventprotein aggregatepublic health relevancerapid diagnosisresearch studyrespiratoryrespiratory virus
项目摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to develop an in vitro culture system to study the etiology and pathogenesis of Kawasaki Disease (KD). KD is the leading cause of acquired heart disease in children in developed nations, and can result in coronary artery aneurysms, myocardial infarction and sudden death. The etiologic agent of KD is unknown, although clinical and epidemiologic features point to a ubiquitous infectious agent that may cause severe disease in a genetically susceptible population. We found that KD patients harbor oligoclonal (antigen-driven) IgA plasma cells in the coronary arteries and other inflamed tissues. Using the variable regions from the IgA heavy chains, we made synthetic KD antibodies in vitro and used them in immunohistochemistry experiments on acute KD and control tissues. We found that KD synthetic antibodies detected antigen in acute KD but not control tissues. Interestingly, we detected antigen in the ciliated bronchial epithelium of KD patients, indicating that the respiratory tract is the likely portal of entry for the KD agent. Using light and transmission electron microscopy (TEM), we found that this antigen resides in cytoplasmic inclusion bodies consistent with aggregates of protein and associated nucleic acid. We hypothesize that bronchial epithelial cells are the initial site of replication of the KD agent, which then spreads to target tissues such as the coronary arteries. We propose to exploit human ciliated bronchial epithelial cells to cultivate the KD agent in vitro. Our specific aims are to 1) Determine if clinical respiratory samples from acute KD patients infect ciliated bronchial epithelial cell cultures in vitro and 2) Use sequence-independent amplification techniques to amplify, clone and sequence novel nucleic acid sequences from the cell-free supernatant of KD-infected cultures. These studies are exciting because for the first time, a cell likely to contain the KD agent, the ciliated bronchial epithelial cell, has been identified and can be subjected to careful study using electron microscopy and cell culture methods. Developing a cell culture system for the KD agent would allow for remarkable advances in diagnosis, therapy, and prevention of this increasingly recognized and potentially fatal childhood disease. PUBLIC HEALTH RELEVANCE. Kawasaki Disease (KD) is a childhood illness that can result in heart attacks and sudden death, but the cause of the disease is unknown, and therefore there is no specific test to allow for rapid diagnosis. We propose to culture cells from human airways and infect those cells with respiratory samples from KD patients to propagate the KD agent in the laboratory. Our goals are to identify the genetic information of the KD agent from these cells, and to develop a specific diagnostic test so that children with this disease can be diagnosed accurately and treated immediately to prevent fatalities.
描述(由申请人提供):本提案的目标是开发一种体外培养系统来研究川崎病(KD)的病因和发病机制。 KD 是发达国家儿童获得性心脏病的主要原因,可导致冠状动脉瘤、心肌梗塞和猝死。川崎病的病因尚不清楚,但临床和流行病学特征表明存在一种普遍存在的传染原,可能在遗传易感人群中引起严重疾病。我们发现川崎病患者的冠状动脉和其他发炎组织中含有寡克隆(抗原驱动)IgA 浆细胞。利用 IgA 重链的可变区,我们在体外制备了合成的 KD 抗体,并将其用于急性 KD 和对照组织的免疫组织化学实验中。我们发现,KD 合成抗体可检测到急性 KD 中的抗原,但未检测到对照组织中的抗原。有趣的是,我们在川崎病患者的纤毛支气管上皮中检测到了抗原,表明呼吸道可能是川崎病药剂的进入门户。使用光学和透射电子显微镜(TEM),我们发现该抗原存在于与蛋白质和相关核酸的聚集体一致的细胞质包涵体中。我们假设支气管上皮细胞是 KD 剂复制的初始位点,然后扩散到冠状动脉等目标组织。我们建议利用人纤毛支气管上皮细胞在体外培养 KD 剂。我们的具体目标是 1) 确定来自急性川崎病患者的临床呼吸道样本是否在体外感染纤毛支气管上皮细胞培养物,以及 2) 使用序列无关的扩增技术从无细胞上清液中扩增、克隆和测序新的核酸序列KD 感染的培养物。这些研究令人兴奋,因为首次鉴定出可能含有 KD 剂的细胞(纤毛支气管上皮细胞),并且可以使用电子显微镜和细胞培养方法对其进行仔细研究。为 KD 制剂开发细胞培养系统将使这种日益被认识的潜在致命儿童疾病的诊断、治疗和预防取得显着进展。公共卫生相关性。川崎病(KD)是一种儿童疾病,可导致心脏病发作和猝死,但该病的病因尚不清楚,因此没有特定的测试可以快速诊断。我们建议培养来自人类呼吸道的细胞,并用来自川崎病患者的呼吸道样本感染这些细胞,以在实验室中传播川崎病制剂。我们的目标是从这些细胞中识别 KD 因子的遗传信息,并开发一种特定的诊断测试,以便患有这种疾病的儿童能够得到准确的诊断和立即治疗,以防止死亡。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Morphogenesis of Coronavirus HCoV-NL63 in Cell Culture: A Transmission Electron Microscopic Study.
细胞培养中冠状病毒 HCoV-NL63 的形态发生:透射电子显微镜研究。
- DOI:10.2174/1874279300802010052
- 发表时间:2009-01-02
- 期刊:
- 影响因子:0
- 作者:J. Orenstein;Bridget S Banach;S. Baker
- 通讯作者:S. Baker
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan C. Baker其他文献
A cross-continental comparison of plant and beetle responses to retention of forest patches during timber harvest.
木材采伐期间植物和甲虫对保留森林斑块的反应的跨大陆比较。
- DOI:
10.1002/eap.1406 - 发表时间:
2016-12-01 - 期刊:
- 影响因子:0
- 作者:
Susan C. Baker;Susan C. Baker;Charles B. Halpern;Tim Wardlaw;C. Kern;G. Edgar;Russell J. Thomson;R. Bigley;J. Franklin;K. Gandhi;L. Gustafsson;S. Johnson;B. Palik;T. Spies;E. Steel;J. Weslien;J. Strengbom - 通讯作者:
J. Strengbom
Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases
冠状病毒类木瓜蛋白酶的去泛素化和干扰素拮抗活性
- DOI:
10.1128/jvi.02406-09 - 发表时间:
- 期刊:
- 影响因子:5.4
- 作者:
Mark A. Clementz;Arun K. Ghosh;Kui Li;Andrew D. Mesecar;Susan C. Baker;陈忠斌;Bridget S. Banach;Yanhua Wang;Li Sun;Kiira Ratia;Yahira M. Baez-Santos;Jie Wang;Jun Takayama - 通讯作者:
Jun Takayama
The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase
猪流行性腹泻病毒的木瓜蛋白酶样蛋白酶通过作为病毒去泛素酶负调节I型干扰素途径
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:3.8
- 作者:
Hongyan Shi;Susan C. Baker;Li Feng;Zhongbin Chen - 通讯作者:
Zhongbin Chen
Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling
冠状病毒木瓜蛋白酶样蛋白酶通过破坏 STING 介导的信号传导来负调节抗病毒先天免疫反应
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Li Sun;Susan C. Baker;Bridget S. Banach;Mark A. Clementz;Kui Li;Daniel B. Nichols;Yaling Xing;陈忠斌;Yang Zheng;Xiaojuan Chen;Yudong Yang - 通讯作者:
Yudong Yang
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
接受抗病毒治疗的免疫抑制患者中 SARS-CoV-2 趋同进化的证据
- DOI:
10.1186/s12985-024-02378-y - 发表时间:
2024-05-07 - 期刊:
- 影响因子:4.8
- 作者:
Shuchen Feng;Gail E Reid;Nina M Clark;Am;a Harrington;a;S. Uprichard;Susan C. Baker - 通讯作者:
Susan C. Baker
Susan C. Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan C. Baker', 18)}}的其他基金
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10206579 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10657457 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10449132 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10882676 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8099729 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8291352 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
9096719 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
7987943 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8485522 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8686719 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
相似国自然基金
流体剪切力在胸主动脉瘤向胸主动脉夹层演变中的作用及机制研究
- 批准号:12372315
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
腹主动脉瘤患者肠道噬菌体组异常及其病因学作用和机制的研究
- 批准号:82370481
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
核因子КB受体活化因子配体在腹主动脉瘤形成中的作用及机制研究
- 批准号:82370486
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞参与腹主动脉瘤发生的关键基因鉴定及Trem2在腹主动脉瘤中的作用研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
基于CTA血流动力学组学智能评估颅内小动脉瘤稳定性的研究
- 批准号:82302300
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Complement Activation in Severe COVID-19
补体激活在严重 COVID-19 中的作用
- 批准号:
10512248 - 财政年份:2022
- 资助金额:
$ 19.22万 - 项目类别:
Role of Complement Activation in Severe COVID-19
补体激活在严重 COVID-19 中的作用
- 批准号:
10687821 - 财政年份:2022
- 资助金额:
$ 19.22万 - 项目类别:
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
- 批准号:
10657443 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
- 批准号:
10427424 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis
靶向 Sirt-1 通路调节小鼠川崎病血管炎期间的炎症
- 批准号:
10281090 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别: